• Designing a Value-Based Formulary for a Commercial Health Plan: A Simulated Case Study of Diabetes Medications [Editor's Choice]

    Jul 1, 2023, 00:00

  • Intention to Treat or per Protocol? Overly Optimistic Findings Regarding the Cost-Effectiveness of 99DOTS, a Tuberculosis Digital Adherence Technology

    Jul 1, 2023, 00:00

  • Copyright/Subscription

    Jul 1, 2023, 00:00

  • The Impact of Subclinical Hypothyroidism on the Quality of Life During Pregnancy: Mapping 5-Level Version of EQ-5D and ThyPRO-39

    Jul 1, 2023, 00:00

  • Use of Utility and Disability Weights in Economic Evaluation of Pediatric Vaccines

    Jul 1, 2023, 00:00

  • Editorial Board

    Jun 28, 2023, 09:01

  • Editorial Board

    Jun 1, 2023, 08:52

  • CO124 Real-World Reduction of Oral Corticosteroid Use in Patients Treated with Dupilumab and with Moderate-to-Severe Asthma

    Jun 1, 2023, 00:00

  • MT38 Novel Data Capture Method for the Identification of Potential Flare Events in Chronic Diseases Via Patient Self-Tracking: Insights from Use Case in Sickle Cell Disease (SCD)

    Jun 1, 2023, 00:00

  • EE45 Cost-Effectiveness of Venetoclax in Combination with Rituximab in Relapsed/Refractory Chroniclymphocytic Leukemia in Four Gulf Countries

    Jun 1, 2023, 00:00

  • CO163 Associations between Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors (EGFR-TKIS) and Venous Thromboembolism Among Older Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)

    Jun 1, 2023, 00:00

  • Medical Technologies

    Jun 1, 2023, 00:00

  • PCR70 Patient and Physician Concordance in Treatment Satisfaction and Symptom Severity Among Male and Female Myasthenia Gravis Patients in the United States and Five European Countries

    Jun 1, 2023, 00:00

  • EE248 Patient-Informed Value Elements for Economic Evaluation of Treatment for Major Depressive Disorder: A Systematic Review and Synthesis

    Jun 1, 2023, 00:00

  • Current Health State Affected Patient Preferences More Than Disease Status: A Discrete Choice Experiment in Multiple Myeloma

    Jun 1, 2023, 00:00

  • EE562 Cost-Effectiveness of the Dengue Vaccine TAK-003 in Thailand

    Jun 1, 2023, 00:00

  • HPR146 Specialty Pharmacy Use and Adherence to Oral Anticancer Medications for Breast Cancer and Prostate Cancer: Implications for Medicare Part D Policy

    Jun 1, 2023, 00:00

  • EPH86 Associations between Depression and HIV Testing / Risk Behaviors in the United States

    Jun 1, 2023, 00:00

  • RWD50 Characteristics of Health Insurance Coverage in Patients with Active and Nonactive Progressive Multiple Sclerosis in the United States

    Jun 1, 2023, 00:00

  • EE258 National Trends in Costs and Site of Service of Infused Disease Modifying Therapies for Multiple Sclerosis

    Jun 1, 2023, 00:00

  • EPH26 Barriers to in-Person Focus Group Participation during the Third-Year of COVID-19 Pandemic: A Case Study of Colorectal Cancer (CRC) Screening in Underrepresented Groups

    Jun 1, 2023, 00:00

  • SA25 A Novel Patient-Reported Outcome Instrument for Meibomian Gland Dysfunction Disease Impact

    Jun 1, 2023, 00:00

  • EE137 Comparison of the Cost-Effectiveness of Sequential Treatment with Abaloparatide Followed By Alendronate between US Women and Men at Increased Risk of Fracture

    Jun 1, 2023, 00:00

  • RWD68 Early Optimal Recovery As a Composite Outcome to Measure Value of Care in Patients Undergoing Primary Total Knee Arthroplasty with a New Implant Design

    Jun 1, 2023, 00:00

  • PCR37 Translation and Cultural Adaptation of the Glaucoma Quality of Life-15 Questionnaire to the Romanian Population

    Jun 1, 2023, 00:00

  • MSR107 Assessment of the Power of ITCs to Detect Minimally Important Treatment Effects in Subsequent Head-to-Head Trials

    Jun 1, 2023, 00:00

  • CO43 Burden of Surgery in Desmoid Tumors

    Jun 1, 2023, 00:00

  • EPH97 Application of Self-Protective Behaviors in Balancing Objective and Subjective COVID-19 Risk Assessments Among Residents in an Urban Setting

    Jun 1, 2023, 00:00

  • CO179 Potential Health and Economic Outcomes of a Blood-Based Genomic Test As a Prescreen for Lung Cancer in the US Medicare Population

    Jun 1, 2023, 00:00

  • EE76 Budget Impact of Faricimab in Patients with Diabetic Macular Edema and Neovascular Age Related Degeneration in Canada

    Jun 1, 2023, 00:00

  • CO180 Persistent Opioid Use after Hospital Admissions for Surgery in New Zealand

    Jun 1, 2023, 00:00

  • EE495 Cost-Effectiveness of Pembrolizumab + Axitinib Versus Nivolumab + Ipilimumab As First-Line Treatment of Advanced Renal Cell Carcinoma in the Private Healthcare System in Brazil

    Jun 1, 2023, 00:00

  • EE296 The Total Cost of Preeclampsia in the Ecuadorian Health System

    Jun 1, 2023, 00:00

  • PCR12 Delayed Care Among Low-Income Adults during the COVID-19 Pandemic: A US Population-Based Study

    Jun 1, 2023, 00:00

  • MSR14 Association of Social Determinants of Health and HIV Pre-Exposure Prophylaxis (PREP) to Need Ratio on the County Level in the United States

    Jun 1, 2023, 00:00

  • RWD71 Managing Uncertainty in US and Spain: How Can Outcomes-Based Agreements Provide Solutions to This?

    Jun 1, 2023, 00:00

  • PCR57 The Role of Patient Activation and Social Support in Health Management Among US Adults with Type 2 Diabetes

    Jun 1, 2023, 00:00

  • P43 Critical Appraisal of Drug Pricing for Advanced Breast Cancer Medications Approvals in Brazil (2007 - 2022) and Comparison with Major National Economic Indicators

    Jun 1, 2023, 00:00

  • MSR94 Unraveling the Threads of Overlapping Coverage Among the Three Most Commonly Explored Biomedical Databases

    Jun 1, 2023, 00:00

  • EE128 Cost-Effectiveness of Switching from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide Vs. Entecavir for Chronic Hepatitis B Patients in Greece

    Jun 1, 2023, 00:00

  • HTA67 Evidence Gaps in Evaluating Comparative Effectiveness, Safety, and Cost-Effectiveness of Biologics in Health Technology Assessment (HTA) Submissions for the Treatment of Severe Asthma

    Jun 1, 2023, 00:00

  • MSR29 Application of Bayesian Multi-Parameter Evidence Synthesis to Achieve Clinical Plausibility of Lifetime Survival Extrapolations in First-Line Advanced Non-Small Cell Lung Cancer (aNSCLC)

    Jun 1, 2023, 00:00

  • PCR131 Expanded Diagnoses Outside of Specialized Amyloidosis Centers: Results from the Amyloidosis Research Consortium's 2022 Community Survey

    Jun 1, 2023, 00:00

  • EE180 Indirect Costs Associated with Preterm Birth in the United States

    Jun 1, 2023, 00:00

  • EE457 Major Ischemic or Hemorrhagic Events and Associated Costs Among Anticoagulated Patients with Non-Valvular Atrial Fibrillation in US Health Plans

    Jun 1, 2023, 00:00

  • EE429 Cost-Effectiveness of Sotagliflozin for the Treatment of Recent Worsening Heart Failure with Diabetes

    Jun 1, 2023, 00:00

  • HTA33 Using the Single Profile Preference Method to Estimate Value Sets for Expanded Descriptive Systems

    Jun 1, 2023, 00:00

  • HPR59 Influence of Institute for Clinical and Economic Review (ICER) Reports in Formulary Decision Making

    Jun 1, 2023, 00:00

  • HPR145 Authorizations of Therapeutic Biologics in Saudi Arabia and the US (1982-2021)

    Jun 1, 2023, 00:00

  • PCR11 Minority Stressors, HIV/AIDS Acquisition Stress, Prep Stigma, and Willingness to Use Prep Among Men Who Have Sex with Men: A Latent Profile Analysis

    Jun 1, 2023, 00:00

  • CO103 Real-World Effectiveness of Sotrovimab for the Early Treatment of COVID-19: Evidence from the National COVID Cohort Collaborative (N3C)

    Jun 1, 2023, 00:00

  • HTA24 The Use of Real-World Data in Decision Making for Oncology: A Review of Recent Health Technology Appraisals in the United Kingdom

    Jun 1, 2023, 00:00

  • EE301 Patient Characteristics, Healthcare Resource Utilization, and Costs for Persistent Chronic Cough Vs. Chronic Cough without Persistent Cough in the United States

    Jun 1, 2023, 00:00

  • HSD84 Prescription Antitussive Use Trajectories and Their Characteristics Among Patients with Chronic Cough in Florida

    Jun 1, 2023, 00:00

  • HPR127 Evaluation of the Spatial Accessibility to Inpatient Services in Beijing, China

    Jun 1, 2023, 00:00

  • OP2 Race and Social Determinants of Health Data Inform Blue Cross and Blue Shield of Louisiana’s Understanding of Its Medicare Advantage Members

    Jun 1, 2023, 00:00

  • SA33 Healthcare Utilization Among Veterans with Alzheimer's Disease Identified from Clinical Notes

    Jun 1, 2023, 00:00

  • OP4 Prioritization of ADT Notifications Improves Efficiency of New Blue Cross and Blue Shield of Louisiana Care Management Referral Process

    Jun 1, 2023, 00:00

  • RWD24 Veno-Occlusive Disease (VOD) Incidence and Treatment Trends Insights from Latest Systematic Review of Case Reports (2018-2023)

    Jun 1, 2023, 00:00

  • EE499 Real-World Outpatient Cost of Care Among Patients with Non-Small Cell Lung Cancer (NSCLC) Treated in the US Community

    Jun 1, 2023, 00:00

  • EE424 Economic Burden of Chronic Kidney Disease in India: A Targeted Literature Review

    Jun 1, 2023, 00:00

  • MSR100 Validation of a Mixed Model for Repeated Measures Approach to Including Trials with Varying Follow-up in Indirect Treatment Comparisons of Long-Term Outcomes

    Jun 1, 2023, 00:00

  • EPH102 Modeling the Population Health Impact of Nicotine Misperceptions

    Jun 1, 2023, 00:00

  • HTA99 Advancing Towards International HTA Collaboration: A Review of International Network Activities to Support HTA Efforts in Ex-Europe Low-Middle-Income Countries (LMICS)

    Jun 1, 2023, 00:00

  • CO36 Keratometry, Intraocular Pressure, and Visual Acuity at the Onset of Ophthalmic Conditions in the Real-World Setting

    Jun 1, 2023, 00:00

  • HPR115 Patient and Provider Factors Associated with Filgrastim Biosimilar Uptake in the U.S.

    Jun 1, 2023, 00:00

  • EE14 Cost-Effectiveness of Non-Pharmaceutical Interventions (NPI), Vaccines and the Combination of NPI and Vaccines in Managing the COVID Pandemic

    Jun 1, 2023, 00:00

  • EE89 The Impact of Different Discounting Rates on Cost-Effectiveness Outcomes in Chronic Disease Populations: Hemophilia A As an Exemplary Disease

    Jun 1, 2023, 00:00

  • EE449 Use of Novel and Social Elements of Value in Cost-Effectiveness Analyses

    Jun 1, 2023, 00:00

  • HSD68 Improving Care Via Timely Health Information Exchange: A Blue Cross and Blue Shield of Louisiana ADT System Referral Program Evaluation

    Jun 1, 2023, 00:00

  • PCR80 Analysis of the Use of Instruments for Collecting Patient-Reported Outcomes (PROS) in Pediatric Asthma Research

    Jun 1, 2023, 00:00

  • EPH51 Algorithms for Identifying Immunocompromised Adults in Administrative Claims Data – a Targeted Literature Review

    Jun 1, 2023, 00:00

  • RWD157 Healthcare Resource Utilization and Cost of Care in Patients with BRAF-Mutated Unresectable/Metastatic Melanoma in the US

    Jun 1, 2023, 00:00

  • HPR31 Value-Based Purchasing Arrangements in Medicaid Programs: Targeted Review

    Jun 1, 2023, 00:00

  • EE285 Evaluating the Face Validity of Health State Utility Values (HSUVS) for Metachromatic Leukodystrophy (MLD)

    Jun 1, 2023, 00:00

  • HSD70 Strategies Used and Degree of Implementation of Clinical Practice Guidelines during the Year 2022 in Colombia: Descriptive Observational Study

    Jun 1, 2023, 00:00

  • EE568 Challenges to Hepatitis C Treatment Access in Vietnam: A Micro-Costing Study

    Jun 1, 2023, 00:00

  • PCR147 Investigating the Patterns of Health-Related Quality of Life and Factors Associated with It Using Latent Class Analysis Among West Virginians

    Jun 1, 2023, 00:00

  • PCR77 “It Shocks Me That There Is Not Something like This Already in Place”: Patient Perspectives for Enhancing Pan-Canadian Data Sharing for Precision Oncology

    Jun 1, 2023, 00:00

  • HSD4 Opioid Use Among Migraine Patients Treated with Acute and Preventive Treatment

    Jun 1, 2023, 00:00

  • EPH10 Carbapenem-Resistant Gram-Negative Pathogens in Brazil: Analysis from Patients in a Laboratory Network

    Jun 1, 2023, 00:00

  • RWD124 Understanding the Value of Chart Abstraction for Assessing Oral Treatment History in the Oncology Outpatient Setting

    Jun 1, 2023, 00:00

  • CO157 Recurrence-Free Survival (RFS) As a Surrogate Endpoint for Overall Survival (OS) in Adults with Early-Stage Hepatocellular Carcinoma (HCC): A Correlation Meta-Analysis of Randomized Controlled Trials (RCTS)

    Jun 1, 2023, 00:00

  • EE61 Cost Effectiveness of Treating Ivig-Resistant Kawasaki Disease Children with Second Round IVIG Versus Infliximab

    Jun 1, 2023, 00:00

  • CO80 Improvements in Activity and Work Productivity in Patients Treated with Mepolizumab across Eosinophilic Diseases

    Jun 1, 2023, 00:00

  • EPH62 Annual Burden of Non-COVID-19 Respiratory Tract Infections in the Pre- to Post- Pandemic Eras: Analysis from the Anlitiks’ All Payor Claims Database

    Jun 1, 2023, 00:00

  • CO142 Evaluating the Impact of the COVID-19 Pandemic on Acute Ischemic Stroke Outcomes in the Stroke Belt

    Jun 1, 2023, 00:00

  • HPR54 A Review and Evaluation of the UK’s Innovative Licensing and Access Pathway

    Jun 1, 2023, 00:00

  • EE360 Measuring Catastrophic Costs Due to Tuberculosis in Colombia, 2021

    Jun 1, 2023, 00:00

  • CO217 Treatment Options for Management of Facial Angiofibroma Associated with Tuberous Sclerosis Complex: A Systematic Review of Evidence of Clinical Effectiveness and Cost-Effectiveness

    Jun 1, 2023, 00:00

  • SA27 Utility Maximization Vs Regret Minimization: Choice Behavior Under Uncertainty

    Jun 1, 2023, 00:00

  • HSD103 Impact of COVID-19 on Delivery of Cancer Care: Real-World Insights from Community Oncology Research Evaluations (CORE)

    Jun 1, 2023, 00:00

  • EPH87 COPD Exacerbation Profile in Chile: Preliminary Results from Integramédica Cohort 2018–2020

    Jun 1, 2023, 00:00

  • EE37 Economic Burden Associated with Immune-Related Adverse Events Induced By Immune Checkpoint Inhibitors Among Older Adults with Non-Small Cell Lung Cancer

    Jun 1, 2023, 00:00

  • MSR58 Relating Heterotopic Ossification Volume to Joint Function And Quality of Life: A Simulation Study in Fibrodysplasia Ossificans Progressiva (FOP)

    Jun 1, 2023, 00:00

  • HTA25 Factors Including Real-World Evidence (RWE) That Play a Role in the HTA Recommendation of Oncology Drug Submissions Based on Phase II and/or Single Arm Trial Data

    Jun 1, 2023, 00:00

  • CO27 Real-World Treatment Response and Persistence Among Black and Non-Black Patients with Metastatic Castration-Sensitive Prostate Cancer Treated with Apalutamide in a Urology Setting

    Jun 1, 2023, 00:00

  • CO174 Prescription Patterns of Antidiabetic Agent and Renal Effectiveness Among Patients with Diabetic Kidney Disease

    Jun 1, 2023, 00:00

  • CO117 Real-World Treatment Patterns and Outcomes in Unresectable Advanced and Metastatic Biliary Tract Cancers (BTC): A Literature Review

    Jun 1, 2023, 00:00

  • HTA49 Cost-Utility Analysis of Pneumococcal Vaccines for Older Adults Available in El Salvador

    Jun 1, 2023, 00:00

  • RWD36 Healthcare Resource Utilization in Patients with Hidradenitis Suppurativa in Five European Countries and the USA Using Real World Evidence

    Jun 1, 2023, 00:00

  • HPR81 Effect of Medicare Eligibility at Age 65 Years on Prescription of High-Risk Medications in Individuals with Multiple Chronic Conditions

    Jun 1, 2023, 00:00

  • CO189 Metabolic and Bariatric Surgery Utilization Trends in the United States: Evidence from 2012–2021 National Electronic Medical Records Data

    Jun 1, 2023, 00:00

  • CO176 Spinal Muscular Atrophy (SMA) Disease-Related Complications Decreased Over Time after Start of Nusinersen Treatment

    Jun 1, 2023, 00:00

  • RWD7 Reproduction of the Control Group in REMDACTA Trial Using the Millennial Medical Record, an Electric Health Record Database, in Japan

    Jun 1, 2023, 00:00

  • EPH139 A Secondary Analysis of the Cross-Cultural Validation of Multi-Dimensional Postpartum Health PROMs, and Suggestions for Improving Their Validity and Administration

    Jun 1, 2023, 00:00

  • HSD110 Trends in the Therapeutic Management of Localized Scleroderma in the Real-World Setting

    Jun 1, 2023, 00:00

  • HSD77 Use and Prescribing Patterns of Disease Modifying Agents in Patients with Multiple Sclerosis Based on Payer Type and Prescribers’ Specialty

    Jun 1, 2023, 00:00

  • EE141 Treatment Patterns and Health Care Spending Among Medicare Beneficiaries with Huntington's Disease

    Jun 1, 2023, 00:00

  • PCR128 Measurement of Health-Related Quality of Life in Pediatric Genetic Conditions: A Scoping Review

    Jun 1, 2023, 00:00

  • MT42 HTA Landscape of Medical Devices in Canada

    Jun 1, 2023, 00:00

  • HPR12 Patient Reported Outcomes in Psoriasis Over Time: Differences By Sex from Three Cross-Sectional, Real World Studies in the United States

    Jun 1, 2023, 00:00

  • MSR95 Impact of Adherence on Real-World Performance of Multi Cancer Early Detection (MCED) Tests: A Model-Based Analysis

    Jun 1, 2023, 00:00

  • CO63 Comparative Clinical Effectiveness of Monoclonal Antibodies for the Treatment of Relapsing Multiple Sclerosis: A Systematic Review and Network Meta-Analysis

    Jun 1, 2023, 00:00

  • EPH2 Using Drug Package Insert Data to Identify Statin-Related Prescribing Cascades - an Evaluation of Findings from Side Effect Resource (SIDER) and Commercial Claims Data

    Jun 1, 2023, 00:00

  • MSR17 Imputation of Line-Level Medical Costs Using a Gradient Descent Boosting Regressor Model

    Jun 1, 2023, 00:00

  • CO71 The Impact of Socioeconomic Status (SES), Insurance Type, and Treatment Facility on Survival in Metastatic Prostate Cancer (MPC): A Systematic Literature Review (SLR) of Social Determinants of Health (SDOH)

    Jun 1, 2023, 00:00

  • CO26 Impact in Health Outcomes of Anti-PD(L)1 Inhibitors to Treat Early-Stage Cancers in Belgium

    Jun 1, 2023, 00:00

  • EE44 Estimating a Cost-Effectiveness Threshold for Health Care Decision-Making in China: Oncology Prevention Versus Treatment

    Jun 1, 2023, 00:00

  • EE188 Budget Impact Analysis of Faricimab for Treating Patients with Diabetes Macular Edema or Neovascular Age-Related Macular Degeneration in Panama

    Jun 1, 2023, 00:00

  • CO86 Improving External Validity of Trial Outcomes When Estimating Subgroup QALY Gains: A Case Study of Pembrolizumab±Chemotherapy Vs. Cetuximab+Platinum-Based Chemotherapy (‘EXTREME’) in Squamous Cell Carcinoma of the Head and Neck

    Jun 1, 2023, 00:00

  • PCR127 Eliciting Patient Experience for Value Assessment in a Case Study of Spinal Muscular Atrophy

    Jun 1, 2023, 00:00

  • PCR110 Characteristics and Comorbid Conditions Associated with Treatment Discontinuation Among Patients Being Treated for Obesity

    Jun 1, 2023, 00:00

  • PCR160 Suitability of Patient-Reported Outcomes Measure Information System (PROMIS) Parent Proxy (PP) Mobility Questionnaire in Typically Developing Children Aged 3-4 Years

    Jun 1, 2023, 00:00

  • HTA37 Incorporation of Clinical Experts in Health Technology Assessment: A Literature Review

    Jun 1, 2023, 00:00

  • EPH91 Factors Associated with Anemia Based on an Analysis of National Health and Nutrition Examination Survey Data

    Jun 1, 2023, 00:00

  • RWD97 Implementing a Quality Assurance Program for Technology-Enabled Curation of Oncology Real-World Data

    Jun 1, 2023, 00:00

  • PCR217 Healthcare Resource Utilization Among Hormone Receptor-Positive and Negative Breast Cancer Patients in the Real-World Setting

    Jun 1, 2023, 00:00

  • EE22 Risk Factors and Healthcare Costs Associated with Long Bone Fracture Non-Union – A US Claims Database Analysis

    Jun 1, 2023, 00:00

  • EE535 Economic Evaluation of Decennial Pertussis Vaccination with Tetanus, Diphtheria and Acellular Pertussis (TDAP) Vaccine in Adult Populations with Asthma or Chronic Obstructive Pulmonary Disease (COPD) in Brazil

    Jun 1, 2023, 00:00

  • EPH134 Accurately Counting Cancer Patients: An Epidemiologic Model to Estimate the Prevalence of Epithelial Ovarian Cancer (EOC) While Accounting for Cure

    Jun 1, 2023, 00:00

  • RWD105 To What Extent Is Allocation of Higher KDPI Score Kidney Transplantation Occurring in the US?

    Jun 1, 2023, 00:00

  • EPH119 Systematic Review and Meta-Analysis of Clinical Outcomes of Bone Grafting/Reconstruction Following Segmental Long Bone Defects Treated By Induced Membrane Technique

    Jun 1, 2023, 00:00

  • EE149 Modelling First-Line Daratumumab Use in Newly-Diagnosed, Transplant-Ineligible Multiple Myeloma in Singapore

    Jun 1, 2023, 00:00

  • PCR155 Does It Look like Evidence? Assessing the Stated-Preference Evidence Base for Inflammatory Bowel Disease

    Jun 1, 2023, 00:00

  • EE23 Economic Impact of Discontinuation and Relapse Rates Among Patients with Schizophrenia Newly Initiated on Lybalvi Versus Olanzapine during First Year Use

    Jun 1, 2023, 00:00

  • RWD172 Incidence and Burden of Bronchiectasis in Patients with Primary Immunodeficiency (PI) Diseases

    Jun 1, 2023, 00:00

  • PCR14 Sociodemographic Indicators and Quality of Life Impact of Major Depressive Disorder in the United States Using the Medical Expenditure Panel Survey

    Jun 1, 2023, 00:00

  • EE526 Cost-Effectiveness Analysis of Transthyretin-Associated Amyloid Cardiomyopathy from the Brazilian Public Healthcare System Perspective

    Jun 1, 2023, 00:00

  • HPR51 Should Volume-Based Procurement Price of Comparator be Referenced for Innovative Drugs in National Reimbursement Drug List Negotiation in China?

    Jun 1, 2023, 00:00

  • RWD59 Association of Time of Loss of Ambulation with Severity of Respiratory Symptoms in Patients with Nonsense Mutation Duchenne Muscular Dystrophy (NMDMD)

    Jun 1, 2023, 00:00

  • PCR23 Methodological Considerations Related to Patient-Reported Outcomes Data (PRO) within HTA Appraisals Reviewed By Institut Für Qualität Und Wirtschaftlichkeit Im Gesundheitswesen (IQWIG) – Example of Triple-Negative Breast Cancer

    Jun 1, 2023, 00:00

  • SA16 Trial Tokenization Accelerating Innovation in SEPRA – A Pragmatic Randomized Trial

    Jun 1, 2023, 00:00

  • Study Approaches

    Jun 1, 2023, 00:00

  • EE480 Economic Burden of Major Depressive Disorder in the United States in 2019-2020: A Societal Perspective

    Jun 1, 2023, 00:00

  • OP17 Pilot Study Evaluating the Trends in Utilization of Compounded Products Pre- and Post- COVID-19 Pandemic

    Jun 1, 2023, 00:00

  • HPR48 Comparing Out-of-Pocket Spending on Ultra-Expensive Drugs in Medicare Part D and the Commercially Insured Population

    Jun 1, 2023, 00:00

  • MSR43 Survival Estimates Using Hazard Ratios Derived from Network Meta-Analyses: Recommendations for Reference Curves

    Jun 1, 2023, 00:00

  • MSR62 Applying Mixture Cure Survival Modeling to Medication Persistence Analysis

    Jun 1, 2023, 00:00

  • EE378 Targeted Literature Review of Non-Payer Costing in Societal-Perspective Oncology Cost Effectiveness Models

    Jun 1, 2023, 00:00

  • HPR36 Utilization of Glucagon-like Peptide-1 Receptor Agonists in Canada

    Jun 1, 2023, 00:00

  • CO111 A Systematic Literature Review of Patient-Reported Outcomes in Phase III Randomized Controlled Trials of Hepatocellular Carcinoma in a First-Line Setting

    Jun 1, 2023, 00:00

  • PCR3 Pain-Free Injections for Growth Hormone Deficiency (GHD) Improve Quality of Life: A Time Trade-Off (TTO) Study in the UK and Canada

    Jun 1, 2023, 00:00

  • CO74 Impact of Current Management on QOL and Mental Health in Pre and Postmenopausal Breast Cancer Patients; An Epidemiological Observational Study in a Tertiary Care Hospital in South India

    Jun 1, 2023, 00:00

  • RWD34 Comparison of Implant Surgery and Readmissions Costs for DBS and VNS

    Jun 1, 2023, 00:00

  • HPR113 Trends in Elective Contraception Procedures in Those of Childbearing Age Enrolled in a Large Commercial Health Plan Surrounding Key Legal and Policy Events from 2008 to 2022

    Jun 1, 2023, 00:00

  • RWD167 Clinical Characteristics, Patterns of Care and Healthcare Resource Utilization (HCRU) in US Patients with Claims for Uterine Fibroids (UF) and Heavy Menstrual Bleeding (HMB) Stratified By Race

    Jun 1, 2023, 00:00

  • EE94 Pharmacogenetic HLA-B*58:01 Testing to Prevent Allopurinol-Induced SJS/TEN in Vietnamese Population: A Cost-Effectiveness Analysis

    Jun 1, 2023, 00:00

  • RWD126 Burden of Clostridium Difficile Infection Among Elderly Cancer Patients in the United States – A Population-Based Study

    Jun 1, 2023, 00:00

  • PCR231 The Mosaic Study: A Clinical and Humanistic Burden of Illness Study Among Patients with Geographic Atrophy (GA) and Their Caregivers in the United States (US) and Canada (CA)

    Jun 1, 2023, 00:00

  • EE118 Short-Term Direct Cost Drivers in Type 1 Diabetes in Latin-American Countries: A Systematic Review

    Jun 1, 2023, 00:00

  • EE414 Health Economic Evaluation of Early Initiation of Grass Sublingual Immunotherapy Tablets in Children

    Jun 1, 2023, 00:00

  • RWD113 Understanding Burden and Drivers of Long Hospital Length of Stay in Patients with Heart Failure with Reduced Ejection Fraction (HFREF)

    Jun 1, 2023, 00:00

  • CO4 Outcomes of Non–Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Patients with Atrial Fibrillation and Diabetes Mellitus: A Systematic Review of Randomized Controlled Trials and Observational Studies

    Jun 1, 2023, 00:00

  • EPH262 Preventing COVID-19 Outbreaks Using Wastewater Surveillance at Long-Term Care Facilities: A Pilot Modelling Study

    Jun 1, 2023, 00:00

  • CO227 An Updated Umbrella Review Comparing the Safety and Effectiveness of Femtosecond Laser-Assisted Cataract Surgery with Manual Cataract Surgery

    Jun 1, 2023, 00:00

  • Budget Impact Analysis of Health Interventions

    Jun 1, 2023, 00:00

  • EE39 Use of Work Productivity Instruments for Adult Cancer Patients in Economic Studies: A Systematic Literature Review

    Jun 1, 2023, 00:00

  • MT19 The Past, Present, and an Outlook on the Future of Evidence Development for Digital Therapeutics

    Jun 1, 2023, 00:00

  • HSD5 Patient and Caregiver Spinal Muscular Atrophy (SMA) Treatment Attribute Preferences in Latin America

    Jun 1, 2023, 00:00

  • SA52 Assessing Missing Antineoplastic Therapy Prior to Electronic Health Record (EHR)-Derived First Line of Therapy after Advanced Non-Small Cell Lung Cancer (ANSCLC) Diagnosis

    Jun 1, 2023, 00:00

  • SA66 The Changing Landscape of Indirect-Treatment Comparison Models for NSCLC in NICE Appraisals: Do Complex Models Fare Well?

    Jun 1, 2023, 00:00

  • CO224 Dupilumab Reduces Itch in Children with Moderate-to-Severe Atopic Dermatitis Aged 6 Months to 5 Years

    Jun 1, 2023, 00:00

  • EE430 Cost-Effectiveness of Tremelimumab or Tremelimumab in Combination with Durvalumab Vs Durvalumab As Treatment of Advanced Hepatocellular Carcinoma

    Jun 1, 2023, 00:00

  • CO172 Immunosuppression Therapy in Retinal Pigmented Epithelial Cell Transplantation: A Targeted Literature Review

    Jun 1, 2023, 00:00

  • MT54 Evolving Landscape of Oncology Biosimilars: In-Depth Interview of Stakeholders Regarding Bevacizumab and Trastuzumab Biosimilar

    Jun 1, 2023, 00:00

  • HSD9 Impact of Participation in Colorectal Cancer Screening during the COVID-19 Pandemic in Japan

    Jun 1, 2023, 00:00

  • EE29 Cost-Effectiveness Analysis and Budgetary Impact of Telescopic Rods for Treatment of Fractures and Correction of Bone Deformities in Children with Osteogenesis Imperfecta in the Brazilian Public Health System

    Jun 1, 2023, 00:00

  • HPR19 Variation in Medicaid and Commercial Coverage of Cell and Gene Therapies

    Jun 1, 2023, 00:00

  • EE42 Economic Evaluation of Donafenib Versus Sorafenib in First-Line Treatment of Unresectable or Metastatic Hepatocellular Carcinoma in Japan

    Jun 1, 2023, 00:00

  • EE376 Estimated Financial Impact of the Drug Cladribine Incorporation for the Relapsing-Remitting Multiple Sclerosis Treatment (RRMS) in a Health Insurance Company in Brazil

    Jun 1, 2023, 00:00

  • EPH76 Association of Lynch Syndrome with Breast Cancer: An Exploratory Analysis Using Claims Data

    Jun 1, 2023, 00:00

  • HPR43 The Influence and Implementation of Pathways of Care for Hematologists Compared to Oncologists in the United States

    Jun 1, 2023, 00:00

  • EPH150 A Survey of Prescription Abandonment and Primary Medication Nonadherence Rates: A Literature Review

    Jun 1, 2023, 00:00

  • EE229 The Effect of COVID-19 on Care for Chronic Wounds Among Medicare Beneficiaries Using Medicare Claims – 2019, 2020, and 2021

    Jun 1, 2023, 00:00

  • EE36 Cost-Effectiveness Analysis of Taptest and Continuous Lumbar Drainage in Comparison to Standard Care in Suspected Idiopathic Normal Pressure Hydrocephalus from the Perspective of the Brazilian Unified Health System

    Jun 1, 2023, 00:00

  • PCR156 Effects of Shared Decision-Making on Customer Satisfaction and Repetition of Rehabilitation Uncovered By Insuran A Retrospective Cohort Study in Japan

    Jun 1, 2023, 00:00

  • SA70 Patient-Reported Outcomes and Daily Activity Assessed with a Digital Wearable Device (FITBIT™) in Patients with Paroxysmal Nocturnal Hemoglobinuria Treated with Ravulizumab: The Reveal Study

    Jun 1, 2023, 00:00

  • EE134 An Overview of Systematic Literature Review of Economic Evaluation of Treatment on Patients with Alzheimer’s Disease and Related Dementia

    Jun 1, 2023, 00:00

  • SA64 Comparative Effectiveness of Bimekizumab in Patients with Psoriatic Arthritis: Results from a Systematic Literature Review and Network Meta-Analysis

    Jun 1, 2023, 00:00

  • PCR200 Healthcare Providers' Perspective and Lessons Learned on a Multimorbidity Approach in the Public Health System of Chile

    Jun 1, 2023, 00:00

  • CO82 Dupilumab Is Effective in Patients with Atopic Dermatitis and Inadequate Response, Intolerance, or Contraindication to Cyclosporine: A Systematic Review and Meta-Analysis

    Jun 1, 2023, 00:00

  • RWD118 Long-Term Neurologic Sequelae Among Patients with Varying COVID-19 Severity: An Administrative Claims Database Analysis

    Jun 1, 2023, 00:00

  • EE486 Osteoporosis Treatment Ranking in Postmenopausal Women at High Risk of Fracture in Brazil: MCDA Approach

    Jun 1, 2023, 00:00

  • EE243 Cost-Effectiveness of Velpatasvir/Sofosbuvir for the Treatment of Hepatitis C in Colombia

    Jun 1, 2023, 00:00

  • EE385 Value of Next Generation Sequencing (NGS) Using the Oncoextra Test in Advanced Cancer Patients

    Jun 1, 2023, 00:00

  • MT4 Implementation of Minimally Invasive Thyroidectomy for Cancer Care: Conversion Rates Are Associated with Facility Learning Curve but Not Total Volume of Thyroidectomies

    Jun 1, 2023, 00:00

  • EE227 The Impact of Treatment-Related Changes in Lipids on the Cost-Effectiveness of Resmetirom and Obeticholic Acid for Treatment of Nonalcoholic Steatohepatitis

    Jun 1, 2023, 00:00

  • Health Policy Regulatory

    Jun 1, 2023, 00:00

  • EE482 Public, Private, and Out-of-Pocket Spending Comparisons between Opioid and Non-Opioid Users, 2008-2019

    Jun 1, 2023, 00:00

  • EE265 Excess Out-of-Pocket Expenditures and Burden of Prescription Opioid Use Among Older Cancer Survivors with Non-Cancer Chronic Pain Conditions (NCPC)

    Jun 1, 2023, 00:00

  • HSD81 Trends in Systemic Therapy Utilization Among Older Patients with Advanced Cutaneous Melanoma: A Population-Based Study

    Jun 1, 2023, 00:00

  • RWD72 Trends in Registration of Real-World Evidence Studies in ClinicalTrials.gov

    Jun 1, 2023, 00:00

  • HSD82 Economic Burden and Service Utilisation of Children with Attention-Deficit/Hyperactivity Disorder (ADHD) - A Systematic Review and Meta-Analysis

    Jun 1, 2023, 00:00

  • EE138 Healthcare Resource Utilization and Costs Associated with Psychiatric Comorbidities in Adult Patients with Attention-Deficit/Hyperactivity Disorder

    Jun 1, 2023, 00:00

  • SA47 Characteristics of United States Counties Utilized for Heart Failure Clinical Trial Sites

    Jun 1, 2023, 00:00

  • PCR106 Comparing Maximum-Acceptable Risk Estimates from 2 Preference-Elicitation Methods: A Discrete-Choice Experiment and a Threshold-Technique Exercise

    Jun 1, 2023, 00:00

  • MSR89 A Novel Visualisation for Assessing the Consistency Assumption in Network Meta-Analysis

    Jun 1, 2023, 00:00

  • EPH232 The Large Hidden Prevalence Rate of Cancer Using Backward Induction Method Reveals Screening Opportunity in Earlier Stages

    Jun 1, 2023, 00:00

  • MSR45 Identifying Longitudinal Treatment Effect Trajectories Using Flexible Outcome Modeling and Clustering

    Jun 1, 2023, 00:00

  • RWD122 The Application of Artificial Intelligence for Enhanced Diagnosis of Prostate Cancer Using Biopsy Evidence That Are Substantiated By Genetic Markers

    Jun 1, 2023, 00:00

  • PCR205 Assessment of Healthcare Resource Utilization in Patients with Exocrine Pancreatic Insufficiency in the Pact-CP Registry

    Jun 1, 2023, 00:00

  • EE359 Cost-Utility of Bictegravir/Tenofovir Alafenamide/Emtricitabine in Naive Patients over 18 Years of Age Living with Human Immunodeficiency Virus Type 1 Infection, from the Colombian’s Health System Perspective

    Jun 1, 2023, 00:00

  • EE181 The Economic Burden of Preterm Labor (PTL): A Systematic Literature Review

    Jun 1, 2023, 00:00

  • PCR140 Identification of Country-Specific Indicators Related to Medication Adherence across 39 European Countries and Israel

    Jun 1, 2023, 00:00

  • EE231 In Search of Baseline Parameters for T1D in Latin America: A Systemic Review of Glycemic Control

    Jun 1, 2023, 00:00

  • HSD87 Racial Disparities in Opioid Prescribing By Patient and Prescriber Race

    Jun 1, 2023, 00:00

  • EE537 Quantifying Annual Medical Economic Burden of Patents and Regulatory Exclusivities on Ics/Laba Inhalers Among End-Stage COPD Patients

    Jun 1, 2023, 00:00

  • PCR129 Development of a Conceptual Model COA Measurement Strategy in Propionic Acidemia/Methylmalonic Acidemia

    Jun 1, 2023, 00:00

  • RWD8 Clinical Characteristics of Patients with Agitation Episodes Associated with Bipolar Disorder or Schizophrenia – Real World Patient Journey

    Jun 1, 2023, 00:00

  • EE164 Cost-Effectiveness of Nivolumab Plus Ipilimumab in Gastro-Oesophageal Cancer in Japan

    Jun 1, 2023, 00:00

  • EE266 Societal Economic Impact of Treatment with Adjuvant Osimertinib in Patients with Early-Stage (IB-IIIA) EGFRm NSCLC

    Jun 1, 2023, 00:00

  • HPR32 Tracking Progress Towards Equitable Maternal and Child Health in Yunnan: A Systematic Assessment for the Health Programme for Poverty Alleviation in China during 2015-2020

    Jun 1, 2023, 00:00

  • EE221 Cost Effectiveness Analyses for Approaches Addressing Geographical Inequalities of Stroke Care: A Systematic Review

    Jun 1, 2023, 00:00

  • HTA18 An Assessment of the Evolving Methods and Role of Health Equity Factors in ICER’s Final Evidence Reports

    Jun 1, 2023, 00:00

  • HTA58 Cost-Utility Analysis of Palivizumab to Prevent Respiratory Syncytial Virus Infections in the Dominican Republic

    Jun 1, 2023, 00:00

  • HSD40 Workflow Efficiencies for Flexible Cystoscopy: Comparing Single-Use Vs Reusable Cystoscopes

    Jun 1, 2023, 00:00

  • RWD78 Characterization of Patients Treated with Semaglutide 2.4MG for Chronic Weight Management: A Retrospective Cohort Study

    Jun 1, 2023, 00:00

  • MT20 Data Visualization As a Tool to Quickly Understand Patient-Generated Data

    Jun 1, 2023, 00:00

  • OP6 Targets Selection Strategy of Bispecific Antibodies in RD from the Perspective of Technology Flows

    Jun 1, 2023, 00:00

  • EPH78 Economic Burden and Healthcare Resource Use in Medicare Beneficiaries with Myelodysplastic Syndromes

    Jun 1, 2023, 00:00

  • HSD13 Emergency Department Hyperkalemia Outcomes Are Improved with Newer Potassium Binders

    Jun 1, 2023, 00:00

  • EPH204 COVID-19 Vaccination during Pregnancy: A Structured Electronic Medical Record Data Study

    Jun 1, 2023, 00:00

  • EPH146 Signal Detection Using Data from FDA Adverse Event Reporting System (FAERS): Infections in Biologics Vs Biosimilars

    Jun 1, 2023, 00:00

  • HTA7 The Price of Innovation – Oncology Treatments Expenditures: Case from Bulgaria

    Jun 1, 2023, 00:00

  • PCR245 Native Arabic Children Speakers' Inputs on the Arabic Translation of International Questionnaires Measuring Fatigue

    Jun 1, 2023, 00:00

  • EE111 Direct Cost of Prenatal Control in a Cohort of Pregnant Women in Colombia

    Jun 1, 2023, 00:00

  • RWD138 Detection and Assessment of Herbal- Drug Interaction Project: SFDA Experience

    Jun 1, 2023, 00:00

  • EE163 A Review of US Budget Impact Analysis of Treatments in Metatastic Non-Small Cell Lung Cancer

    Jun 1, 2023, 00:00

  • CO197 Burden of Disease Associated with Bictegravir/Tenofovir Alafenamide/Emtricitabine in Adults Infected with Human Immunodeficiency Virus Type 1: A Rapid Systematic Review

    Jun 1, 2023, 00:00

  • PCR227 Utility Estimates for Vision Loss in Leber’s Hereditary Optic Neuropathy

    Jun 1, 2023, 00:00

  • PCR148 Validation of the Chinese Version of the Icecap-O Questionnaires Among Older People with Disabilities

    Jun 1, 2023, 00:00

  • EE397 Budget Impact Analysis of Nivolumab Plus Ipilimumab for the Management of Advanced Unresected Malignant Pleural Mesothelioma (MPM)

    Jun 1, 2023, 00:00

  • EPH258 Assessing Different Combinations of 4CMENB and Menacwy-CRM197 Vaccines in Infants, Toddlers and Adolescents of Argentina to Maximize Its Impact Against Invasive Meningococcal Disease

    Jun 1, 2023, 00:00

  • EPH136 Available Screening Programs for the Early Identification of Cancers: A Targeted Literature Review

    Jun 1, 2023, 00:00

  • EE294 Workplace Productivity Loss Associated with Preterm Birth in the United States

    Jun 1, 2023, 00:00

  • PCR241 Intentions Regarding Genetic Testing Among the US Population: A Survey Using Theory of Planned Behavior (TPB)

    Jun 1, 2023, 00:00

  • CO53 Clinical Benefits of Treating Patients with Type 2 Diabetes Mellitus with iGlarLixi: A Patient-Level Simulation Study

    Jun 1, 2023, 00:00

  • SA23 Demographic and Clinical Charcterization in Younger Patients with Multiple Myeloma

    Jun 1, 2023, 00:00

  • HSD18 Patient Experience of Using Telehealth Services during COVID-19 in Dubai Health Authority: A Retrospective Cross-Sectional Electronic Survey

    Jun 1, 2023, 00:00

  • PCR36 Vision-Related Quality of Life and Mental Health Outcomes of Children and Young People with Visual Impairment and Their Carers

    Jun 1, 2023, 00:00

  • HTA68 How Do ICER’s Assessments of Comparative Effectiveness Compare to the German Federal Joint Committee’s Assessments of Added Benefit?

    Jun 1, 2023, 00:00

  • HPR86 The Inflation Reduction Act in Effect: Implications for Pharmaceutical Research and Development (RD)

    Jun 1, 2023, 00:00

  • CO37 A Systematic Review of Pharmacological and Non-Pharmacological Migraine Management Strategies Among Community Dwelling Adults

    Jun 1, 2023, 00:00

  • EPH234 Cancer-Related Disease Trauma: A Public Health Crisis

    Jun 1, 2023, 00:00

  • Generic Price Regulation and Drug Expenditures: Evidence From Canada

    Jun 1, 2023, 00:00

  • EE501 Comparison of Survival Extrapolations Using Early Vs Late Data Cuts from the Echelon-1 Trial in Frontline Advanced Hodgkin Lymphoma

    Jun 1, 2023, 00:00

  • CO133 Clinic and Economic Burden Associated with Intraoperative Hypotension Among High-Risk Surgical Patients in Taiwan: A Retrospective Cohort Study

    Jun 1, 2023, 00:00

  • EPH180 Examinination of Social Determinants of Health in Women's Health Cancer Screening

    Jun 1, 2023, 00:00

  • CO62 Towards Better Rheumatoid Arthritis Management By Identification of Potentially Manageable Conditions Observed with Early Discontinuation of Biologic/Targeted Synthetic (B/TS) DMARDS

    Jun 1, 2023, 00:00

  • CO91 Surgical Fixation of Multiple Rib Fractures in Asian Population: A Systematic Literature Review and Meta-Analysis

    Jun 1, 2023, 00:00

  • EE269 Cost-Effectiveness of Profile Omission of Local Adjuvant Radiotherapy (POLAR), A Novel Genomic Signature, after Breast Conserving Surgery for Women with Invasive Early-Stage Breast Cancer (ESBC)

    Jun 1, 2023, 00:00

  • PCR67 Health State Utilities for Achondroplasia: A Time Trade-Off Study

    Jun 1, 2023, 00:00

  • RWD18 Age Comparisons across Real-World Evidence Research, Randomized Clinical Trials, and Surveillance, Epidemiology, and End Results (SEER) in Advanced Cancer

    Jun 1, 2023, 00:00

  • EPH153 A Natural Language Processing Solution for Health Economics and Outcomes Research Systematic Literature Review

    Jun 1, 2023, 00:00

  • MSR19 Missing Patient Reported Outcome Data in Clinical Trials: An Overview and Simulation Study

    Jun 1, 2023, 00:00

  • EE31 Identifying Equity-Relevant Subgroup Effects in Alzheimer’s Disease: A Literature Review to Support a Distributional Cost-Effectiveness Analysis

    Jun 1, 2023, 00:00

  • Measuring Financial Toxicity: A Closer Look

    Jun 1, 2023, 00:00

  • SA32 Bridging the Gap for Type 2 Diabetes Management and Peer-Support Interventions for Mental Health Comorbidities in Adult Patients: A Systematic Review

    Jun 1, 2023, 00:00

  • RWD96 Implementation of a Real-World Data Quality Framework in a Nationwide Oncology Electronic Health Record-Derived Database

    Jun 1, 2023, 00:00

  • EPH58 Adverse Events Associated with Sodium Glucose Co-Transporter-2 Inhibitors: A Pharmacoepidemiologic Analysis Using FAERS Database 2012-2022

    Jun 1, 2023, 00:00

  • PCR31 Assessment of Pain, Stiffness, and Physical Functioning Pre and During Burosumab Among Adults with X-Linked Hypophosphatemia: Results from a Multinational, Long-Term, Prospective Outcomes Disease Monitoring Program

    Jun 1, 2023, 00:00

  • OP16 The Importance of Clinical Research Organizations (CRO) in Clinical Research and Impact of COVID-19 Pandemic

    Jun 1, 2023, 00:00

  • RWD108 Vaccine Sentiments on Social Media: A Machine Learning-Powered Real-Time Monitoring System

    Jun 1, 2023, 00:00

  • MSR6 Assessing the Impact of Early Albumin Administration in Patients Requiring Intravascular Resuscitation: Application of Machine Learning Techniques to Electronic Health Record (EHR) Data

    Jun 1, 2023, 00:00

  • P31 The Association between Patient- and Caregiver-Reported Utility Values in Duchenne Muscular Dystrophy (DMD)

    Jun 1, 2023, 00:00

  • Cost-Effectiveness of Nadofaragene Firadenovec and Pembrolizumab in Bacillus Calmette-Guérin Immunotherapy Unresponsive Non–Muscle Invasive Bladder Cancer

    Jun 1, 2023, 00:00

  • EE451 Using Real-World Evidence to Support Reimbursement Decision-Making in China: Current Practices, Challenges and Opportunities

    Jun 1, 2023, 00:00

  • EE483 Health Care Expenditures for Substance Use Disorders: A Comparative National Study

    Jun 1, 2023, 00:00

  • PCR158 Preferences for Online Pre-Exposure Prophylaxis Delivery Among Potential Clients in Kenya: A Discrete Choice Experiment

    Jun 1, 2023, 00:00

  • P30 Psychometric Evaluation of Two Novel Hyperphagia Questionnaires for Patients with Bardet-Biedl Syndrome (BBS)

    Jun 1, 2023, 00:00

  • EE307 Budget Impact Analysis of Upadacitinib for Moderate-to-Severe Atopic Dermatitis for Social Security and Private Third-Party Payers in Argentina

    Jun 1, 2023, 00:00

  • HSD43 Waste Savings on Health in a Value-Based Drug Safety Program in Patients with Chronic High-Cost Diseases

    Jun 1, 2023, 00:00

  • HPR8 Accelerating Access to Promising New Pediatric Medicines in Canada: Comparing International Approaches to Regulation and Reimbursement

    Jun 1, 2023, 00:00

  • PCR105 Patient Risk-Benefit Preferences for Transcatheter Versus Surgical Mitral Valve Repair

    Jun 1, 2023, 00:00

  • EPH115 The Effect of Non-Steroidal Anti-Inflammatory Drugs on C-Reactive Protein Levels and Mortality in Patients with Sepsis

    Jun 1, 2023, 00:00

  • EE182 CFTR-Modulators (CFTRM) Impact on Real-World Healthcare Resource Utilisation (HCRU) in Cystic Fibrosis (CF) in Wales: Retrospective, Observational, Database Study Using Linked Data from the UK CF Registry (UKCFR) and Sail-Databank

    Jun 1, 2023, 00:00

  • EE434 Is Academic Detailing on Naloxone Distribution for Patients at Risk for an Opioid Overdose Good Value for Money? Application of a Probabilistic Sensitivity Analysis in a Cost-Effectiveness Framework

    Jun 1, 2023, 00:00

  • EPH212 Drug Prices and Crime: An Empirical Study Examining Northern Central America

    Jun 1, 2023, 00:00

  • EE220 12-Month Mortality and Healthcare Utilization in a Real-World Patient Population with Severe Tricuspid Regurgitation

    Jun 1, 2023, 00:00

  • CO131 Off Pump Coronary Artery Bypass (OPCAB) Versus on Pump Coronary Artery Bypass Grafting (CABG) with Cardiopulmonary Bypass; An Umbrella Review

    Jun 1, 2023, 00:00

  • EPH48 Evolution of Polypharmacy and Prescribed Drug Expenditure: The Case of an Insured Poor Population in the Colombian Caribbean during 2018-2021

    Jun 1, 2023, 00:00

  • HTA48 Coverage and Reimbursement of Cell and Gene Therapies: Population Health Versus Individual Patient Perspectives

    Jun 1, 2023, 00:00

  • EE18 Cost-Effectiveness Analysis of the Aspergillus Galactomannan Enzyme Immunoassay in the Brazilian Public Health System

    Jun 1, 2023, 00:00

  • SA30 Online Survey Implementation in Clinical Research – Methodological Lessons Learnt

    Jun 1, 2023, 00:00

  • PCR41 Trust and Customer Satisfaction with Services Provided By Pharmacy Staff

    Jun 1, 2023, 00:00

  • HSD95 Enhancing Heart Failure (HF) Management—Coupling Predictive Model with Clinical Insights Using Administrative Data

    Jun 1, 2023, 00:00

  • EPH172 Real-World Trends of Patients with Syphilis in Japan Using Integrated Data of IQVIA Claims, Jast Data and Desc Database

    Jun 1, 2023, 00:00

  • EPH251 Neighborhood Characteristics of Availability of Buprenorphine-Prescribing Clinicians and X-Waivered Clinicians

    Jun 1, 2023, 00:00

  • PCR180 HEREDITARY Angioedema PATIENTS Journey in Mexico a Case Series Report

    Jun 1, 2023, 00:00

  • CO5 The Association of Inflammatory Chronic Conditions with Blood Pressure Control Among Adults with Hypertension in the United States

    Jun 1, 2023, 00:00

  • EE21 COVID-19 Premature Mortality Productivity Losses: Real World Information Analysis

    Jun 1, 2023, 00:00

  • EPH60 Hepatitis B Immunization Rate from 2013 to 2020 Among High-Risk US Adults

    Jun 1, 2023, 00:00

  • EE556 SAVR and TAVR in Aortic Stenosis: Reimbursement and Cost Analysis in Chile for Providers Reference

    Jun 1, 2023, 00:00

  • RWD65 Novel Adverse Events of CGRP Receptor Antagonists: A Disproportionality Analysis in USFDA Adverse Event Reporting System Database

    Jun 1, 2023, 00:00

  • EE178 Healthcare Resource Utilization Among Patients with Sickle Cell Disease with Recurrent Vaso-Occlusive Crises in Germany

    Jun 1, 2023, 00:00

  • EPH179 Empirical Validity of the Quality Measure ‘Adherence to Antipsychotic Medications for Individuals with Schizophrenia’ Among Medicaid Beneficiaries

    Jun 1, 2023, 00:00

  • P48 Oncologists’ and Urologists’ Preferences for First-Line (1L) Treatment of Locally Advanced/Unresectable Metastatic Urothelial Carcinoma (AUC): A Discrete Choice Experiment (DCE) Conducted in 5 European Countries

    Jun 1, 2023, 00:00

  • RWD66 Analysis and Providing of Continuous Professional Development for Pharmacists: Challenges in Wartime in Ukraine

    Jun 1, 2023, 00:00

  • EE464 Cost Effectiveness of a Dietitian Delivered Telephone Coaching Program for Preventing Gestational Diabetes Mellitus

    Jun 1, 2023, 00:00

  • Long Term COVID-19 and Mental Health

    Jun 1, 2023, 00:00

  • CO38 Long-Term Tramadol Use and One-Year Mortality in Patients with Chronic Kidney Disease in South Korea

    Jun 1, 2023, 00:00

  • EE5 Cost Analysis of Antihypertensive Drugs Prescribed in a Tertiary Care Hospital in South Indian City

    Jun 1, 2023, 00:00

  • EE268 Temporal Trends in Adverse Event Costs with Nivolumab + Relatlimab Combination Therapy or Nivolumab Monotherapy for Patients with Unresectable or Metastatic Melanoma

    Jun 1, 2023, 00:00

  • RWD31 Assessment of Pharmacists' Awareness of Anemia Treatment during War Time in Ukraine

    Jun 1, 2023, 00:00

  • EE147 A Cost-Effectiveness Analysis of Pemigatinib Versus Gemcitabine/Cisplatin Therapy in Patients with Cholangiocarcinoma

    Jun 1, 2023, 00:00

  • CO101 Overview of Recent Systematic Literature Reviews on Anti-Obesity Medications in Adults

    Jun 1, 2023, 00:00

  • EE310 Relationships Among Sickle Cell Disease Complications and Their Implications for Cost-Effectiveness Modeling for Therapies with Curative Intent

    Jun 1, 2023, 00:00

  • EE497 Healthcare Costs Associated with Hematopoietic Stem-Cell Transplantation in Patients with Acute Myeloid Leukemia: A Population-Based Retrospective Cohort Study in Korea

    Jun 1, 2023, 00:00

  • EPH142 Assessing Epidemiological Burden of Hereditary Angioedema through Systematic Review of Literatures

    Jun 1, 2023, 00:00

  • CO141 Utilization Trends of Pharmacotherapies Among Patients with Heart Failure with Preserved Ejection Fraction

    Jun 1, 2023, 00:00

  • SA7 A Systematic Literature Review to Assess the Level of Evidence in Facioscapulohumeral Muscular Dystrophy

    Jun 1, 2023, 00:00

  • HTA92 A Review and Evaluation of Successfully Reimbursed Orphan and Non-Orphan Drugs in Ireland

    Jun 1, 2023, 00:00

  • PCR215 Work Productivity Impairment By Type of Worker in Active and Nonactive Progressive Multiple Sclerosis

    Jun 1, 2023, 00:00

  • EPH12 Management of HIV Drug Resistance in the United States: Achieved Success and Areas for Improvement

    Jun 1, 2023, 00:00

  • P14 A Case Study Using Keynote-024 to Examine the Impact of Cut-Point Selection on Long-Term Survival Estimates from Piecewise Modeling

    Jun 1, 2023, 00:00

  • SA36 Economic Burden of Esophageal Cancer: A Systematic Review of Global Evidence

    Jun 1, 2023, 00:00

  • EE290 Assessing the Utility of Existing Hereditary Angioedema Disease Models for Health Economic Evaluation of Future Therapies

    Jun 1, 2023, 00:00

  • MSR12 Identifying the Patterns of Clinical Phenotypes Impacting Kidney Disease Progression: A Latent Class Analysis Approach

    Jun 1, 2023, 00:00

  • EPH152 Evaluating Postoperative Complication Risk in Patients with Nicotine Dependence That Undergo Mohs Micrographic Surgery

    Jun 1, 2023, 00:00

  • P24 Interpretable Machine Learning Prediction of Treatment Switching Among Patients with Multiple Sclerosis: An Electronic Medical Records Analysis

    Jun 1, 2023, 00:00

  • EE93 TAVR Reimbursement and Cost Analysis in Chile: Input Data for Improving the DRG System in Chile

    Jun 1, 2023, 00:00

  • MSR35 Data Pre-Processing Approaches in Predictive Machine Learning Observational Studies

    Jun 1, 2023, 00:00

  • CO15 Bacteremia, Sepsis, and Endocarditis Outcomes in Patients with Opioid Use Disorder Treated with a Prescription Digital Therapeutic

    Jun 1, 2023, 00:00

  • PCR198 Engaging Patients in the 10-Step Framework for Continuous Engagement: Challenges and Recommendations

    Jun 1, 2023, 00:00

  • RWD6 Provision of Diet, Exercise, Cholesterol and Hemoglobin A1C Testing in Office Based Medical Visits Among Normal, Overweight, Obese, and Morbidly Obese Individuals in the US

    Jun 1, 2023, 00:00

  • EPH241 Comparison of Comorbidities between Adults and Children with Glycogen Storage Disease Type Ia (GSDIA)

    Jun 1, 2023, 00:00

  • HSD53 Implementation Process of an Interdisciplinary Intervention Strategy for Adults with Chronic Non-Cancer Pain in Primary Care in Chile

    Jun 1, 2023, 00:00

  • EE41 Cost-Utility of Nivolumab Versus Observation for the Adjuvant Treatment of Urothelial Carcinoma (UC) for Patients Who Are at High-Risk of Recurren A Canada Public Payer Perspective

    Jun 1, 2023, 00:00

  • EE407 Healthcare Resource Utilization and Cost Burden of Facial Angiofibroma Associated with Tuberous Sclerosis Complex: A Real-World Claims Database Analysis in the United States

    Jun 1, 2023, 00:00

  • HSD89 The Patient Journey Prior to Neuromodulation in Drug-Resistant Epilepsy, Patterns of Utilization and Cost of Healthcare Services and Pharmacotherapy Based on a Claim Database in the United States

    Jun 1, 2023, 00:00

  • HSD37 Phosphodiesterase Type 5 Inhibitors Prescriber Analysis: Recent Results from US Commercial Population

    Jun 1, 2023, 00:00

  • HPR124 A Review of Managed Entry Agreements and Innovative Payment Models Established for Gene Therapies in the UK, EU4, US, Canada, and Japan

    Jun 1, 2023, 00:00

  • HPR116 US List Prices for Maine’S High-Cost Highly Prescribed Drugs Were over 7-Fold Higher Than the Lowest Canadian Prices

    Jun 1, 2023, 00:00

  • EE335 A Multicenter Microcosting Study for COVID-19 in Brazil

    Jun 1, 2023, 00:00

  • RWD134 Imputation of Disease Severity for Diabetic Retinopathy Clinical Encounters in the Iris® Registry (INTELLIGENT RESEARCH IN SIGHT)

    Jun 1, 2023, 00:00

  • EE539 Estimating the Lifetime Burden of Illness in Patients with Bronchiolitis Obliterans Syndrome (BOS)

    Jun 1, 2023, 00:00

  • RWD14 Time-Dependent Profiling of Distinct Stages Prior to Breast Cancer Onset Using Free-Text Diagnosis Names

    Jun 1, 2023, 00:00

  • EE293 A Cost Analysis on Renal Disease Progression of Fabry Disease Patients Treated with Agalsidase Beta Based on Renal Disease Stage in Colombia

    Jun 1, 2023, 00:00

  • EE447 Methods of Incorporating Changes in Drug Price over Time into Health Economic Evaluations: A Targeted Literature Review

    Jun 1, 2023, 00:00

  • CO13 Evaluating the Impact of Antibiotic Duration on Superinfection after Controlling for Cumulative Spectrum Scores

    Jun 1, 2023, 00:00

  • EE114 Cost-Effectiveness of Multiparametric MRI Compared to Liver Biopsy for the Detection of Nash Among Patients with Type 2 Diabetes Treated with Semaglutide

    Jun 1, 2023, 00:00

  • RWD137 A Real-World Comparative Effectiveness Analysis of Fostamatinib Vs. Thrombopoietic Receptor Agonists (TPOS) for the Treatment of Chronic Immune Thrombocytopenia in Adult Patients

    Jun 1, 2023, 00:00

  • HTA52 Text Analysis of Patient Engagement in HTA

    Jun 1, 2023, 00:00

  • Patient-Centered Research

    Jun 1, 2023, 00:00

  • EE540 Budget Impact of Anti-Inflammatory Reliever Therapy with Budesonide-Formoterol Combination in the Treatment of Mild Asthma in Costa Rica

    Jun 1, 2023, 00:00

  • EE563 Cost-Effectiveness Analysis of Switching from a Trivalent to a Quadrivalent Inactivated Influenza Vaccine in Colombia

    Jun 1, 2023, 00:00

  • CO58 Efficacy and Safety of Pharmacotherapeutic Interventions Used in Visceral Leishmaniasis Clinical Trials: A Systematic Review and Network Meta-Analysis

    Jun 1, 2023, 00:00

  • PCR214 Severe Sialorrhea: Patient Journey and Related Costs Reveal Unmet Medical Needs

    Jun 1, 2023, 00:00

  • HSD42 Utilization and Cost of Molecular Diagnostics and Genetic Testing Prescribed By Various Medical Specialties in the United States

    Jun 1, 2023, 00:00

  • CO24 Simulating the Impact of First-Line Treatment Choice on Survival Among Patients with Locally Advanced/Metastatic Urothelial Carcinoma Considered Cisplatin Ineligible

    Jun 1, 2023, 00:00

  • MT32 Pay-for-Performance Risk-Sharing Arrangements for Medical Technology in China: Application and Prospect

    Jun 1, 2023, 00:00

  • EPH208 Impacts of COVID-19 on Career Choices in Health Professionals and Medical Students

    Jun 1, 2023, 00:00

  • PCR170 Comparing Algorithms for Mapping from EQ-5D-3L to EQ-5D-5L in Two Patient Cohorts

    Jun 1, 2023, 00:00

  • EPH77 Association of Socioeconomic Position and Racial Disparities in Multigene Prognostic Score Measuring Breast Cancer Recurrence Risk

    Jun 1, 2023, 00:00

  • EE551 Impacts on Prices and Expenses with Biological Medicines of the Specialized Component of Pharmaceutical Assistance after the Entry of Biosimilars within the Brazilian Public Health System

    Jun 1, 2023, 00:00

  • HPR18 International Generic Availability Improvements between 2010 and 2021

    Jun 1, 2023, 00:00

  • HTA53 How Can the International Health and Development Communities Support HTA Implementation at the Country Level? A Review of International Cooperation and Collaboration Initiatives in the Americas

    Jun 1, 2023, 00:00

  • EPH49 Did Gender Healthcare Disparity Against Women Exist in Chile during the First Two Years of the Pandemic?

    Jun 1, 2023, 00:00

  • HPR96 A Comparative Analysis of the Relationship between Orphan Drug Status and Reimbursement Status in Ireland, Sweden, France, and Canada in 2022

    Jun 1, 2023, 00:00

  • RWD142 Prospective Monitoring of Patients with COVID-19 Vaccination for Outcomes of Hospitalization Using Electronic Medical Record Network

    Jun 1, 2023, 00:00

  • SA56 Canadian Expert Consensus on Use of Halobetasol Propionate/Tazarotene Lotion for Plaque Psoriasis

    Jun 1, 2023, 00:00

  • HTA38 Accuracy and Economic Evaluation of the Interferon Gamma Release Test (IGRA) for Detection of Latent Infection By Mycobacterium Tuberculosis in Patients with Immune-Mediated Diseases or Receptors of Solid Organ Transplants

    Jun 1, 2023, 00:00

  • HTA43 Do Complexities of Combination Oncology Submissions Impact Reimbursement Outcomes: An Evaluation of Multi-Therapy Oncology Regimens in Canada

    Jun 1, 2023, 00:00

  • HPR131 Examination of CMS National Coverage Analyses and Concordance with Other Decision-Making Bodies

    Jun 1, 2023, 00:00

  • HPR46 Is Innovation Reaching Everyone? an Assessment of Healthcare Equity in Access to Orphan Drugs That Represent a Public Health Concern and Therapeutic Innovation in LATAM

    Jun 1, 2023, 00:00

  • EE254 Analysis of Path of Therapy in the Treatment of Spasticity in Adult Post-Stroke Patients

    Jun 1, 2023, 00:00

  • PCR219 Real-World Severe Symptom Trajectory in Multiple Myeloma Reported in Remote Symptom Monitoring with Electronic Patient-Reported Outcomes (ePRO)

    Jun 1, 2023, 00:00

  • HTA10 Bring out Your Dead: A Review of the Cost Minimization Approach in Health Technology Assessment Submissions to the Australian Pharmaceutical Benefits Advisory Committee

    Jun 1, 2023, 00:00

  • CO106 Comparative Effectiveness of Pharmacological Treatments in Alcohol Use Disorder (AUD) - A Systematic Literature Review (SLR) and Network-Meta Analysis (NMA)

    Jun 1, 2023, 00:00

  • EE506 Targeted Intraoperative Radiation Therapy As an Adjuvant to Surgery for the Treatment of Breast Cancer in England: A UK-Based Cost-Effectiveness Analysis of Intrabeam

    Jun 1, 2023, 00:00

  • HTA44 Economic Modeling Insights for Ultra Orphan Drugs Based on Review of NICE Highly Specialized Technology (HST) Assessment Reports

    Jun 1, 2023, 00:00

  • EPH37 The Role of Prescribed Controlled Substance Acquisition As Potential Triggers of Opioid Overdose: A Case-Crossover Study

    Jun 1, 2023, 00:00

  • CO222 Systematic Literature Review (SLR) of Direct Oral Anticoagulants (DOACS) As a Treatment Option for Acute Heparin-Induced Thrombocytopenia (HIT) with or without Thrombosis

    Jun 1, 2023, 00:00

  • CO18 Reuse of Tumor Necrosis Factor Inhibitors for Treatment of Rheumatoid Arthritis Despite Discordance with Patient-Important Outcomes and Standard Disease Assessments

    Jun 1, 2023, 00:00

  • EE505 Economic Analysis of the Screening Strategy for Lung Cancer with Liquid Biopsy from a Brazilian Perspective

    Jun 1, 2023, 00:00

  • SA68 The Humanistic Burden of Myotonic Dystrophy Type 1: A Literature Review

    Jun 1, 2023, 00:00

  • EE522 Healthcare Resource Use and Costs Among Patients with Erythropoietic Protoporphyria and X-Linked Protoporphyria in the United States

    Jun 1, 2023, 00:00

  • EPH65 The Analysis of Dynamic Processes of Virus Transmission: How Could Diagnostic Tests and Vaccinations Can Stop COVID-19 Pandemic?

    Jun 1, 2023, 00:00

  • EE547 Impact of Inclusion of Finerenone in the Burden of Disease of Chronic Kidney Disease (CKD) in Type 2 Diabetes (T2D) in Central America

    Jun 1, 2023, 00:00

  • EE504 Cost-Effectiveness of a Novel Treatment for Cancer-Associated Thrombosis (CAT): Results from an Early Economic Analysis

    Jun 1, 2023, 00:00

  • EE183 Cost-Effectiveness Model for PTAH Oral Immunotherapy in Peanut Allergy Using Two-Year Extension Trial Data

    Jun 1, 2023, 00:00

  • HTA76 Increased Legal Certainty Surrounding Medicine Discounting May Increase Switzerland’s Attractiveness As an Early Launch Country

    Jun 1, 2023, 00:00

  • CO113 Incidence and Risk Factors of Newly Diagnosed Atrial Fibrillation in Colorectal Cancer Patients

    Jun 1, 2023, 00:00

  • PCR193 An Innovative Patient-Centric Approach to Integrate Patients’ Perspectives in the Selection of Patient-Reported Outcomes

    Jun 1, 2023, 00:00

  • PCR202 Estimating Meaningful Change for the Impact of Weight on Self-Perception (IW-SP) Questionnaire Among People with Type 2 Diabetes

    Jun 1, 2023, 00:00

  • EPH79 Assessment of County-Level Characteristics and Cancer Clinical Trial Rates in the US, 2010-2021

    Jun 1, 2023, 00:00

  • HTA95 Building a Lifecycle Ethics Framework for the Assessment of Artificial Intelligence Technologies in Health: A Scoping Review of Reviews

    Jun 1, 2023, 00:00

  • RWD95 Comparing Representativeness of Race and Ethnicity in Real-World Evidence, Randomized Clinical Trial, and Surveillance, Epidemiology, and End Results (SEER) Cancer Patient Data

    Jun 1, 2023, 00:00

  • HSD90 Value as the Next Innovation in Rectal Cancer Surgery: A Review

    Jun 1, 2023, 00:00
  • «
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28 (current)
  • 29
  • 30
  • »